Investigator-Initiated Pilot Study of Sunitinib Malate in Patients With Newly Diagnosed Prostate Cancer Prior to Prostatectomy.
Phase of Trial: Phase II
Latest Information Update: 01 Oct 2014
At a glance
- Drugs Sunitinib (Primary)
- Indications Prostate cancer
- Focus Therapeutic Use
- 10 Jun 2017 Biomarkers information updated
- 19 Jun 2014 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov record.
- 13 Nov 2012 Planned End Date changed from 1 Dec 2011 to 1 Sep 2013 as reported by ClinicalTrials.gov.